Type 2 diabetes and viral infection; cause and effect of disease
Autor: | Felix M. Wensveen, Dario Rahelić, Tamara Turk Wensveen, Dora Gašparini |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
endocrine system diseases
Endocrinology Diabetes and Metabolism BIOMEDICINE AND HEALTHCARE. Basic Medical Sciences. Immunology Comorbidity Review Disease Type 2 diabetes Global Health antidiabetic drugs COVID-19 corona virus diabetes diabetes mellitus type 2 immune defects immune system immunometabolism infection insulin resistance T2D viral infection 0302 clinical medicine Diabetes mellitus type 2 Endocrinology Risk Factors 030212 general & internal medicine BIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti. Interna medicina Immune defects Viral infection Incidence Diabetes General Medicine 3. Good health Virus Diseases BIOMEDICINA I ZDRAVSTVO. Temeljne medicinske znanosti. Imunologija Infection Corona virus 030209 endocrinology & metabolism Context (language use) 03 medical and health sciences Immune system Insulin resistance Diabetes mellitus medicine Internal Medicine Humans Endocrine system Risk factor BIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences. Internal Medicine Immunometabolism business.industry Antidiabetic drugs nutritional and metabolic diseases medicine.disease Diabetes Mellitus Type 2 Immunology business |
Zdroj: | Diabetes Research and Clinical Practice Volume 172 |
ISSN: | 0168-8227 |
DOI: | 10.1016/j.diabres.2020.108637 |
Popis: | The recent pandemic of COVID-19 has made abundantly clear that Type 2 diabetes (T2D) increases the risk of more frequent and more severe viral infections. At the same time, pro- inflammatory cytokines of an anti-viral Type-I profile promote insulin resistance and form a risk factor for development of T2D. What this illustrates is that there is a reciprocal, detrimental interaction between the immune and endocrine system in the context of T2D. Why these two systems would interact at all long remained unclear. Recent findings indicate that transient changes in systemic metabolism are induced by the immune system as a strategy against viral infection. In people with T2D, this system fails, thereby negatively impacting the antiviral immune response. In addition, immune-mediated changes in systemic metabolism upon infection may aggravate glycemic control in T2D. In this review, we will discuss recent literature that sheds more light on how T2D impairs immune responses to viral infection and how virus-induced activation of the immune system increases risk of development of T2D. |
Databáze: | OpenAIRE |
Externí odkaz: |